CollPlant Biotechnologies Ltd (CLGN) Form 6-K — Oct 29, 2026
CollPlant Biotechnologies (Nasdaq: CLGN) announced that its subsidiary LightSolver has signed an agreement with the Israel Ministry of Defense's DDR&D for the development and delivery of an LPU photonic computing unit. The engagement follows successful proof-of-concept work and transitions to a multi-year framework, with an initial order covering the first 12 months. LightSolver's defense TAM is estimated at up to $5 billion annually with roughly 15% CAGR.
Key figures
- Defense tam cagr
- ~15%
- Initial order period
- first 12 months
- Defense tam annual usd
- $5 billion
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.